The letter warned the company about documentation and quality control issues related to Enduramesh, naming eight violations at its Hinckley, Ohio, facility. The FDA also issued a recall of the device in February.
The Enduramesh product cited is different from the Enduramesh Model 762.XXX, which was cleared by the FDA in April 2010.
More Articles on Spinal Devices:
15 New Spine Devices & Systems to Know
Expanding Orthopedics Receives Patent for Spine Device
Medtronic Pays $85M Settlement in Infuse Lawsuit
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.